THERALASE TECHNOLOGIES INC /FI

TORONTO ONTARIO, A6 · CIK 0000923883 · Medtech · Public

Patented laser technology platforms for bio-stimulative and bio-destructive clinical applications

theralase.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$728K
5 Form D · Aug 2026
1 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$62,622
Private capital raisedForm D · SEC$160,109
Private capital raisedForm D · SEC$323,489
Private capital raisedForm D · SEC$109,080
Private capital raisedForm D · SEC$72,298
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
858CT RESOURCES INC——
859BITE TECH, INC—$29M
860Harland Medical Systems, Inc.—$6.3M
861THERALASE TECHNOLOGIES INC /FI—$728K
862SOLTA MEDICAL INC—$47M
863Gelesis—$38M
864FUSmobile——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Guy AndersonDirector
  • Randy BruderDirector
  • Roger Dumoulin-WhiteDirector · Executive Officer
  • Kristina HacheyDirector · Executive Officer
  • Kaouthar LbiatiDirector
  • Arkady MandelDirector · Executive Officer
  • Matthew ParratonDirector
  • Matthew PerratonDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.